Resolvin D1 (RvD1) Regulates Porphyromonas Gingivalis Lipopolysaccharide-induced Del-1 and Cytokine Expressions in Human Gingival Fibroblasts

Year 2023, Volume: 7 Issue: 2, 635 - 643, 31.05.2023

Serife Buket Bozkurt , Sema Sezgin Hakkı

https://doi.org/10.30621/jbachs.1141356

Abstract

Purpose: To detect the effect of Resolvin D1 (RvD1) on Developmental endothelial locus-1 (Del-1) and cytokine expressions of human gingival fibroblast cells exposed to Porphyromonas gingivalis lipopolysaccharide (P. gingivalis-LPS).

Material and Methods: The effect of RvD1 on cell viability of human gingival fibroblasts exposed to P. gingivalis-LPS were determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Meanwhile, the effect of RvE1 on Del-1 and cytokine (IL-1β, IL-6, IL-8, IL-10, IL-17) expressions of human gingival fibroblasts exposed to P. gingivalis-LPS were studied by real-time PCR experiment, statistical analysis was performed using GraphPad Prism version 5 for Windows.

Results: Cell viability assay results demonstrated that RvD1 concentrations upregulated cell number compared to control group at 24 and at 72 hours. While RvD1 reduced IL-6, IL-8, IL-17 mRNA expression, IL-10 and Del-1 mRNA expression increased as a time- and dose-dependent manner. Also, IL-1β was not affected by RvD1 treatments.

Conclusion: The increased expression of Del-1 and IL-10 by RvD1 down-regulated the pro-inflammatory cytokine expressions induced by P. gingivalis-LPS in gingival fibroblast. RvD1 displayed regulatory effects on gingival inflammation in P. gingivalis LPS-induced cell culture experiment. In particular, results of study display that Del-1 induced by RvD1 may have therapeutic potential to modulate periodontal inflammation.

Keywords

Resolvin D1, cytokine, Del-1, gingival fibroblast

References

• 1.Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016; 15:551–567.
• 2.Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014; 510, 92–101.
• 3.Hasturk H, Kantarci A, Van Dyke TE. Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol. 2012; 15:160–176.
• 4.Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014; 40(3):315-327.
• 5.Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med. 2017; 58:1-11
• 6.Hajishengallis G, Moutsopoulos NM, Hajishengallis E, Chavakis T. Immune and regulatory functions of neutrophils in inflammatory bone loss. Semin Immunol. 2016; 28(2):146-158.
• 7.Bozkurt SB, Hakki SS, Hakki EE, Durak Y, Kantarci A. Porphyromonas gingivalis Lipopolysaccharide Induces a Pro-inflammatory Human Gingival Fibroblast Phenotype. Inflammation. 2017; 40(1):144-153.
• 8.Bozkurt SB, Tuncer Gokdag I, Hakki SS. Porphyromonas gingivalis-Lipopolysaccharide induces cytokines and enzymes of the mouse cementoblasts. Cytokine. 2021; 138:155380.
• 9.Hajishengallis G, Sahingur SE. Novel inflammatory pathways in periodontitis. Adv Dent Res. 2014; 26(1):23-29.
• 10.Eskan MA, Jotwani R, Abe T, et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol. 2012; 13, 465–473.
• 11.Choi EY, Lim J-H, Neuwirth A, et al. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination. Mol Psychiatry. 2014; 20:880–888.
• 12. Maekawa T, Hosur K, Abe T, et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway. Nat Commun 2015; 6:8272.
• 13. Mustafa M, Zarrough A, Bolstad AI, et al. Resolvin D1 protects periodontal ligament. Am J Physiol Cell Physiol. 2013; 305(6):C673-679.
• 14. Khaled M, Shibani NA, Labban N, et al. Effects of resolvin D1 on cell survival and cytokine expression of human gingival fibroblasts. J Periodontol. 2013; 84(12):1838-1846.
• 15. Bozkurt SB, Hakki SS, Hakki EE, Durak Y, Kantarci A. Porphyromonas gingivalis lipopolysaccharide induces a pro-inflammatory human gingival fibroblast phenotype. Inflammation. 2017; 40:144-153.
• 16.Bozkurt SB, Tuncer Gokdag I, Hakki SS. Porphyromonas gingivalis-Lipopolysaccharide induces cytokines and enzymes of the mouse cementoblasts. Cytokine. 2021; 138:155380.
• 17.Ferguson B, Bokka NR, Maddipati KR, et al. Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation. Front Immunol. 2020; 11:1307.
• 18.Duvall MG, Levy BD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol. 2016; 785:144–55.
• 19.Elabdeen HR, Mustafa M, Szklenar M, Ruhl R, Ali R, Bolstad AI. Ratio of pro-resolving and pro-inflammatory lipid mediator precursors as potential markers for aggressive periodontitis. PLoS ONE. 2013; 8:e70838.
• 20.Gaudin A, Tolar M, Peters OA. Lipoxin A4 attenuates the inflammatory response in stem cells of the apical papilla via ALX/FPR2. Sci Rep. 2018; 8:8921.
• 21.Cao D, Pi J, Shan Y, Tang Y, Zhou P. Anti-inflammatory effect of Resolvin D1 on LPS-treated MG-63 cells. Exp Ther Med. 2018; 16(5):4283-4288.
• 22.Li Y-Y, Cai Q, Li B-S, et al. The Effect of Porphyromonas gingivalis Lipopolysaccharide on the Pyroptosis of Gingival Fibroblasts . Inflammation. 2021; 44:3.
• 23.Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: fibroblast biology. J Periodontol. 2003; 74(1):103-110.
• 24.Haase HR, Clarkson RW, Waters MJ, Bartold PM. Growth factor modulation of mitogenic responses and proteoglycan synthesis by human periodontal fibroblasts. J Cell Physiol. 1998; 174(3):353-61.
• 25.Saxenaa S, Venugopalb R, Raob RC, Yuwanatia MB, Awasthib H, Jaina M. Association of chronic periodontitis and type 2 diabetes mellitus with salivary Del-1 and IL-17 levels. J Oral Biol Craniofac Res. 2020; 10(4):529-534.
• 26.Shin J, Hosur KB, Pyaram K, et al. Expression and function of the homeostatic molecule Del-1 in endothelial cells and the periodontal tissue. Clin Dev Immunol. 2013; 2013:1–12.
• 27.Hajishengallis G, Sahingur SE. Novel inflammatory pathways in periodontitis. Adv Dent Res. 2014; 26(1):23-29.
• 28.Inonu E, Kayis SA, Eskan MA, Hakki SS. Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease. J Periodontal Res. 2020; 55(4):511-518.